Our support of the study program being conducted by Brigham and Women's Hospital is a sign of our shared commitment to help improve healthcare delivery and outcomes for the estimated five million patients with non-valvular atrial fibrillation in the U.S. who are at increased risk for stroke, said Sabine Luik, M.D., senior vice president, medicine & regulatory affairs, U.S. regional medical direc